Cat. No. | Product name | CAS No. |
DC20935 |
CV-6209
A highly potent, selective platelet activating factor (PAF) inhibitor with IC50 of 75 and 170 nM for aggregation inhibition of rabbit and human platelets induced by PAF. |
100488-87-7 |
DC23518 |
PF-470
A highly potent, selective, and efficacious metabotropic glutamate receptor 5 (mGluR5) negative allosteric modulator with Ki of 0.9 nM, IC50 of 2.5 nM. |
1539296-45-1 |
DC21658 |
SKI-2852
A highly potent, selective, and orally bioavailable 11β-HSD1 inhibitor with IC50 of 2.9 and 1.6 nM for hHSD1 and mHSD1, respectively. |
1346554-47-9 |
DC20964 |
Razaxaban
A highly potent, selective, and orally bioavailable factor Xa (FXa) inhibitor with Ki of o.19 nM, >5,000-fold selectivity over a series of related serine proteases. |
218298-21-6 |
DC20965 |
Razaxaban hydrochloride
A highly potent, selective, and orally bioavailable factor Xa (FXa) inhibitor with Ki of o.19 nM, >5,000-fold selectivity over a series of related serine proteases. |
405940-76-3 |
DC23466 |
GRN-529
A highly potent, selective, orally active mGluR5 negative allosteric modulator with Ki of 5.4 nM, IC50 of 3.1 nM. |
1253291-12-1 |
DC23863 |
eCF506
A highly potent, selective, orally available Src family kinase inhibitor with IC50 of <0.5 nM, <0.5 nM and for Src, Yes and Fyn kinases respectively, >950-fold selectivity for Src over ABL. |
1914078-41-3 |
DC23972 |
MK-2894 sodium
A highly potent, selective, second generation prostaglandin E2 subtype 4 receptor (EP4) antagonist with Ki of 0.56 nM. |
1006036-88-9 |
DC22972 |
S-17092
A highly potent, specific and cell permeant inhibitor of human proline endopeptidase (PE) with Ki of 1 nM. |
176797-26-5 |
DC21815 |
WAY 163909
A highly potent, subtype-selective agonist of 5-HT2C receptor with Ki of 10.5 nM, >20-fold selectivity over 5-HT2A and 5-HT2B receptor subtypes (IC50=212 and 485 nM, respectively). |
428868-32-0 |
DC26071 |
BMS-814580
Featured
A highly potent, subtype-selective melanin concentrating hormone receptor 1 (MCHR1) inhibitor with Ki of 17 nM, without inhibitory activity for MCHR2 at 10 uM. |
1197420-11-3 |
DC26070 |
BMS 814580 phosphate
A highly potent, subtype-selective melanin concentrating hormone receptor 1 (MCHR1) inhibitor with Ki of 17 nM, without inhibitory activity for MCHR2 at 10 uM. |
1197420-12-4 |
DC22776 |
CCG-224406
A highly selective and potent GRK2 (G protein-coupled receptor kinase 2) inhibitor with IC50 of 130 nM. |
1870843-22-3 |
DC23953 |
Orteronel
A highly selective CYP17A1 (17,20-lyase) inhibitor with IC50 of 17 nM for human 17,20-lyase. |
566939-85-3 |
DC24016 |
Ribocil-C
A highly selective inhibitor of the FMN riboswitch that controls expression of de novo riboflavin (Vitamin B2) biosynthesis in Escherichia coli. |
1825355-56-3 |
DC24089 |
KX2-391 mesylate
Featured
A highly selective, non-ATP competitive substrate-pocket-directed Src/pretubulin inhibitor. |
1080645-95-9 |
DC24090 |
KX2-391 dihydrochloride
Featured
A highly selective, non-ATP competitive substrate-pocket-directed Src/pretubulin inhibitor. |
1038395-65-1 |
DC22902 |
SNC-80
Featured
A highly selective, non-peptide agonist of the δ-opioid receptor (δ-OR) with IC50/Ki of 2.73/0.18 nM. |
156727-74-1 |
DC20704 |
AVN-322 free base
A highly selective, potent, BBB penetrant and orally bioavailable 5-HT6R antagonist for the treatment of neurological disorders such as AD and schizophrenia. |
1194574-33-8 |
DC20707 |
AVN-322
A highly selective, potent, BBB penetrant and orally bioavailable 5-HT6R antagonist for the treatment of neurological disorders such as AD and schizophrenia. |
1194574-68-9 |
DC23330 |
pdTp
A highly selective, small molecule inhibitor of the miRNA regulatory complex RISC subunit SND1. |
2863-04-9 |
DC24154 |
BTS
A highly specific myosin II ATPase inhibitor. |
1576-37-0 |